19 studies found for:    Pulmonary Embolism | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
Pulmonary Embolism | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Assessing the Prognosis of Pulmonary Embolism Using Clinical and Imaging Biomarkers (Retrospective & Prospective )
Condition: Pulmonary Embolism
Intervention:
2 Recruiting Assessment of Acute Disease to Reduce Imaging Costs
Conditions: Acute Coronary Syndrome;   Pulmonary Embolism
Interventions: Device: Pilot Phase;   Device: Intervention group, receive the numeric PTP estimate;   Device: No Intervention
3 Unknown  Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
Conditions: Atrial Fibrillation;   Deep Venous Thrombosis;   Heart Valve Replacement;   Pulmonary Embolism
Intervention: Drug: Coumadin
4 Recruiting A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Conditions: Venous Thromboembolism;   Pulmonary Embolism
Intervention: Drug: dalteparin injection
5 Recruiting Development of Computer-aided Detection and Diagnosis From Imaging Techniques
Condition: Diagnostic Imaging
Intervention:
6 Recruiting The Spot Sign for Predicting and Treating ICH Growth Study
Condition: Intracerebral Hemorrhage
Interventions: Drug: recombinant activated factor VII;   Drug: placebo
7 Recruiting Pharmacogenetics of Warfarin in Puerto Rican Patients Using a Physiogenomics Approach
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Antiphospholipid Syndrome;   Coagulopathy
Intervention:
8 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
9 Recruiting Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)
Conditions: Arterial Thromboembolic Events;   Atrial Fibrillation
Interventions: Drug: Placebo;   Drug: Dalteparin
10 Recruiting Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention: Drug: Recombinant tissue plasminogen activator (rt-PA)
11 Recruiting Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: rosuvastatin
12 Recruiting Red Cell Storage Duration Study
Conditions: Cardiac Surgery;   Erythrocyte Transfusion
Interventions: Biological: Red blood cell units stored <= 10 days;   Biological: Red blood cell units stored >= 21 days
13 Recruiting Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: orteronel;   Drug: triptorelin
14 Unknown  Clinical and Economic Implications of Genetic Testing for Warfarin Management
Condition: Blood Coagulation Disorders
Intervention: Drug: Warfarin
15 Recruiting Operative Strategies to Reduce Cerebral Embolic Events During Coronary Artery Bypass Surgery
Condition: Stroke
Interventions: Procedure: No aortic clamping;   Procedure: partial occluding clamp;   Procedure: single cross clamp;   Procedure: cross clamp and partial occluding clamp
16 Unknown  The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
Conditions: Hypercholesterolemia;   Thrombosis
Interventions: Drug: Clopidogrel;   Drug: Atorvastatin
17 Recruiting Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
Condition: Thromboembolism
Interventions: Other: Pharmacogenetic Warfarin Initiation;   Other: Clinical Warfarin Initiation (non-pharmacogenetic)
18 Recruiting Predictors of Anticoagulation Control on Warfarin Therapy
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Heart Valve Replacement
Intervention:
19 Recruiting Evaluation of the Duration of Therapy for Thrombosis in Children
Condition: Venous Thrombosis
Interventions: Other: Shortened duration (6 weeks) of anticoagulant therapy;   Other: Conventional duration (3 months) of anticoagulant therapy;   Other: No Intervention;   Drug: Dalteparin

Indicates status has not been verified in more than two years